INNOVAR Drug Patent Profile
Which patents cover Innovar, and when can generic versions of Innovar launch?
Innovar is a drug marketed by Epic Pharma Llc and is included in one NDA.
The generic ingredient in INNOVAR is droperidol; fentanyl citrate. There is one drug master file entry for this compound. Additional details are available on the droperidol; fentanyl citrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for INNOVAR?
- What are the global sales for INNOVAR?
- What is Average Wholesale Price for INNOVAR?
Summary for INNOVAR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 94 |
| Patent Applications: | 4,668 |
| DailyMed Link: | INNOVAR at DailyMed |
US Patents and Regulatory Information for INNOVAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epic Pharma Llc | INNOVAR | droperidol; fentanyl citrate | INJECTABLE;INJECTION | 016049-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
